ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 11.08
(-8.05%)
CNY 11.08
(-8.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 781.12 Million CNY | -15.57% |
| 2022 | 689.32 Million CNY | 23.94% |
| 2021 | 564.84 Million CNY | 14.18% |
| 2020 | 502.98 Million CNY | 42.62% |
| 2019 | 364.88 Million CNY | 33.27% |
| 2018 | 273.35 Million CNY | 16.02% |
| 2017 | 211.44 Million CNY | 18.99% |
| 2016 | 181.62 Million CNY | 45.39% |
| 2015 | 142.23 Million CNY | 28.86% |
| 2014 | 99.65 Million CNY | 16.85% |
| 2013 | 81.16 Million CNY | -16.4% |
| 2012 | 108.89 Million CNY | -9.69% |
| 2011 | 116.83 Million CNY | 21.78% |
| 2010 | 100.2 Million CNY | 33.44% |
| 2009 | 74.17 Million CNY | 31.29% |
| 2008 | 57.2 Million CNY | 117.76% |
| 2007 | 25.36 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 102.79 Million CNY | 22.31% |
| 2024 Q1 | 117.46 Million CNY | -19.21% |
| 2024 Q3 | -21.05 Million CNY | -114.42% |
| 2023 Q4 | 105.3 Million CNY | -30.52% |
| 2023 FY | - CNY | -15.57% |
| 2023 Q1 | 173.41 Million CNY | 19.41% |
| 2023 Q2 | 197.72 Million CNY | 14.02% |
| 2023 Q3 | 151.55 Million CNY | -23.35% |
| 2022 Q2 | 173.28 Million CNY | 18.31% |
| 2022 Q3 | 139.93 Million CNY | -19.25% |
| 2022 Q4 | 145.22 Million CNY | 3.78% |
| 2022 FY | - CNY | 23.94% |
| 2022 Q1 | 146.46 Million CNY | 1.99% |
| 2021 Q4 | 143.6 Million CNY | 59.14% |
| 2021 FY | - CNY | 14.18% |
| 2021 Q1 | 105.96 Million CNY | 1.76% |
| 2021 Q2 | 134.74 Million CNY | 27.16% |
| 2021 Q3 | 90.24 Million CNY | -33.03% |
| 2020 Q2 | 137.4 Million CNY | 44.37% |
| 2020 Q1 | 95.17 Million CNY | 18.61% |
| 2020 Q3 | 81.13 Million CNY | -40.96% |
| 2020 FY | - CNY | 42.62% |
| 2020 Q4 | 104.13 Million CNY | 28.36% |
| 2019 Q3 | 54.54 Million CNY | -31.98% |
| 2019 FY | - CNY | 33.27% |
| 2019 Q1 | 68.38 Million CNY | 198.69% |
| 2019 Q2 | 80.18 Million CNY | 17.26% |
| 2019 Q4 | 80.24 Million CNY | 47.13% |
| 2018 FY | - CNY | 16.02% |
| 2018 Q4 | 22.89 Million CNY | -53.22% |
| 2018 Q3 | 48.94 Million CNY | -32.88% |
| 2018 Q2 | 72.92 Million CNY | 26.04% |
| 2018 Q1 | 57.85 Million CNY | 566.69% |
| 2017 Q4 | 8.67 Million CNY | -70.29% |
| 2017 Q2 | 85.59 Million CNY | 106.06% |
| 2017 Q1 | 41.53 Million CNY | -23.1% |
| 2017 FY | - CNY | 18.99% |
| 2017 Q3 | 29.2 Million CNY | -65.88% |
| 2016 Q3 | 39.29 Million CNY | -13.31% |
| 2016 FY | - CNY | 45.39% |
| 2016 Q1 | 31.78 Million CNY | -41.11% |
| 2016 Q2 | 45.33 Million CNY | 42.64% |
| 2016 Q4 | 54.01 Million CNY | 37.45% |
| 2015 Q1 | -113.04 Thousand CNY | -100.49% |
| 2015 FY | - CNY | 28.86% |
| 2015 Q2 | 55.24 Million CNY | 48967.69% |
| 2015 Q3 | 1.73 Million CNY | -96.86% |
| 2015 Q4 | 53.96 Million CNY | 3011.38% |
| 2014 Q3 | 23.77 Million CNY | 63.44% |
| 2014 Q4 | 22.85 Million CNY | -3.86% |
| 2014 FY | - CNY | 16.85% |
| 2014 Q1 | 6.6 Million CNY | -19.81% |
| 2014 Q2 | 14.54 Million CNY | 120.05% |
| 2013 Q4 | 8.24 Million CNY | 8.67% |
| 2013 Q2 | 14.61 Million CNY | -9.94% |
| 2013 Q1 | 16.23 Million CNY | -61.7% |
| 2013 FY | - CNY | -16.4% |
| 2013 Q3 | 7.58 Million CNY | -48.11% |
| 2012 Q3 | 2.11 Million CNY | -89.42% |
| 2012 Q1 | 11.05 Million CNY | -62.41% |
| 2012 Q4 | 42.38 Million CNY | 1900.92% |
| 2012 FY | - CNY | -9.69% |
| 2012 Q2 | 20.01 Million CNY | 81.03% |
| 2011 Q1 | 44.58 Million CNY | 54.92% |
| 2011 FY | - CNY | 21.78% |
| 2011 Q4 | 29.42 Million CNY | 51.83% |
| 2011 Q3 | 19.37 Million CNY | 51.84% |
| 2011 Q2 | 12.76 Million CNY | -71.38% |
| 2010 FY | - CNY | 33.44% |
| 2010 Q2 | 13.36 Million CNY | -55.83% |
| 2010 Q3 | 14.2 Million CNY | 6.31% |
| 2010 Q4 | 28.77 Million CNY | 102.59% |
| 2010 Q1 | 30.25 Million CNY | 104.8% |
| 2009 FY | - CNY | 31.29% |
| 2009 Q3 | 7.53 Million CNY | 0.0% |
| 2009 Q4 | 14.77 Million CNY | 95.92% |
| 2008 FY | - CNY | 117.76% |
| 2007 FY | - CNY | 0.0% |